安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
KA2507, a potent, orally active and selective HDAC6 inhibitor with IC50 of 2.5 nM, shows antitumor activities and immune modulatory effects in preclinical models.
KA2507, a potent, orally active and selective HDAC6 inhibitor with IC50 of 2.5 nM, shows antitumor activities and immune modulatory effects in preclinical models.
[1] Tsimberidou AM, et al. Clin Cancer Res. 2021 Jul 1;27(13):3584-3594.
动态评分
0.0